SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-022019
Filing Date
2017-09-13
Accepted
2017-09-13 17:50:35
Documents
1
Period of Report
2017-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3448
  Complete submission text file 0000899243-17-022019.txt   4775
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4520 EAST-WEST HIGHWAY SUITE 300 BETHESDA MD 20814
Business Address
Ueno Ryuji (Reporting) CIK: 0001384370 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 171083936